Inventor · disambiguated record
Ahmad Hashash
Also filed as: HASHASH AHMAD · HASHASH AHMAD AL
20 granted patents·19 pending applications·49 citations·filing 2006–2025
93Inventor score
Files withCYCLERION THERAPEUTICS INC14IRONWOOD PHARMACEUTICALS INC8PRAXIS PREC MEDICINES INC3SUNESIS PHARMACEUTICALS INC3BIONOMICS LTD2
Top patents by PatentIndex Score
39 records- 0194US11708361B2Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2021·Granted Jul 25, 2023·2 cites·14 claims
- 0293US12030874B2Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2023·Granted Jul 9, 2024·1 cites·20 claims
- 0387US12275724B2Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2024·Granted Apr 15, 2025·0 cites·4 claims
- 0487US11274096B2Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2019·Granted Mar 15, 2022·2 cites·22 claims
- 0587US10889577B2Solid forms of an sGC stimulatorCYCLERION THERAPEUTICS INC·Filed 2017·Granted Jan 12, 2021·3 cites·24 claims
- 0687US8841340B2Solid forms of an antiviral compoundGILEAD SCIENCES INC·Filed 2013·Granted Sep 23, 2014·9 cites·26 claims
- 0784US8138202B2Stable SNS-595 compositions and methods of preparationSUDHAKAR ANANTHA·Filed 2010·Granted Mar 20, 2012·8 cites·6 claims
- 0883US9409891B2Solid forms of an antiviral compoundGILEAD SCIENCES INC·Filed 2014·Granted Aug 9, 2016·5 cites·24 claims
- 0983US2025129060A1Solid forms of an sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1082US11697669B2Hemi-citrate salts of GABA-A positive allosteric modulator and crystalline form thereofPRAXIS PREC MEDICINES INC·Filed 2022·Granted Jul 11, 2023·1 cites·28 claims
- 1182US2024059683A1Solid forms of an sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1282US2024293324A1Solid dispersions comprising a sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1381US2025017862A1Solid dispersions comprising a sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1480US2024246947A1Solid forms of an sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1579US2025073301A1Delayed Release Compositions of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1679US2025361228A1Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1775US2023398173A1Delayed Release Compositions of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1875US2025282769A1Solid forms of an sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1974US9745296B2Salts, co-crystals, and polymorphs of an anxiolytic compoundBIONOMICS LTD·Filed 2014·Granted Aug 29, 2017·2 cites·15 claims
- 2074US8586601B2Stable SNS-595 compositions and methods of preparationSUDHAKAR ANANTHA·Filed 2010·Granted Nov 19, 2013·2 cites·14 claims
- 2173US11572358B2Solid forms of an sGC stimulatorCYCLERION THERAPEUTICS INC·Filed 2020·Granted Feb 7, 2023·0 cites·11 claims
- 2273US7380291B2Airbag equipped garment and deployment systemHASHASH AHMAD AL·Filed 2006·Granted Jun 3, 2008·10 cites·4 claims
- 2373US2023142270A1Delayed Release Compositions of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2472US8202998B2Salts of benzimidazolyl pyridyl ethers and formulations thereofGULLAPALLI RAMPURNA·Filed 2007·Granted Jun 19, 2012·2 cites·3 claims
- 2570US2025255821A1Solid dispersions comprising a sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2667US8324389B2Solid forms of a Raf kinase inhibitorHASHASH AHMAD·Filed 2008·Granted Dec 4, 2012·1 cites·9 claims
- 2767US2024190910A1Hemi-citrate salts of gaba-a positive allosteric modulator and crystalline form thereofPRAXIS PREC MEDICINES INC·Filed 2022·Application pending·0 cites
- 2867US2022202725A1Modified or Targeted Release Formulations of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2966US8455662B2Formulations for benzimidazolyl pyridyl ethersHASHASH AHMAD·Filed 2007·Granted Jun 4, 2013·1 cites·39 claims
- 3063US2016310559A1Delayed Release Compositions of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3161US9469635B2Stable SNS-595 compositions and methods of preparationSUNESIS PHARMACEUTICALS INC·Filed 2013·Granted Oct 18, 2016·0 cites·16 claims
- 3261US2019269619A1Solid dispersions comprising a sgc stimulatorIRONWOOD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3360US2019084978A1Stable sns-595 compositions and methods of preparationSUNESIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3460US2023190662A1Efficacy of a Gastro-Retentive Bile Acid Sequestrant Dosage FormIRONWOOD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3559US9969730B2Stable SNS-595 compositions and methods of preparationSUNESIS PHARMACEUTICALS INC·Filed 2016·Granted May 15, 2018·0 cites·9 claims
- 3659US2025375380A1High strength single unit dose formulations and methods of use thereofPRAXIS PREC MEDICINES INC·Filed 2025·Application pending·0 cites
- 3753US2019350863A1Modified or Targeted Release Formulations of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3850US8501785B2Salts of benzimidazolyl pyridyl ethers and formulations thereofGULLAPALLI RAMPURNA·Filed 2012·Granted Aug 6, 2013·0 cites·24 claims
- 3947US10266529B2Salts, co-crystals, and polymorphs of an anxiolytic compoundBIONOMICS LTD·Filed 2017·Granted Apr 23, 2019·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →